84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]孟愿,石瑛,詹紅生.腸道菌群介導(dǎo)調(diào)節(jié)性T細(xì)胞影響骨代謝的研究進(jìn)[J].中醫(yī)正骨,2023,35(01):43-46.
點(diǎn)擊復(fù)制

腸道菌群介導(dǎo)調(diào)節(jié)性T細(xì)胞影響骨代謝的研究進(jìn)()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第35卷
期數(shù):
2023年01期
頁(yè)碼:
43-46
欄目:
綜述
出版日期:
2023-01-20

文章信息/Info

作者:
孟愿石瑛詹紅生
(上海中醫(yī)藥大學(xué)附屬曙光醫(yī)院,上海 201203)
關(guān)鍵詞:
胃腸道微生物群 T-淋巴細(xì)胞 骨生成 骨質(zhì)吸收 綜述
摘要:
人體腸道內(nèi)的微生物構(gòu)成了復(fù)雜的腸道微生態(tài)系統(tǒng)。腸道菌群能夠通過(guò)免疫系統(tǒng)調(diào)節(jié)、代謝產(chǎn)物分泌等多個(gè)途徑影響骨代謝。調(diào)節(jié)性T細(xì)胞是T細(xì)胞的一個(gè)特殊亞群,其介導(dǎo)的免疫抑制在骨代謝過(guò)程中起重要作用。腸道菌群能夠影響調(diào)節(jié)性T細(xì)胞的分化與功能,進(jìn)而影響骨代謝。本文對(duì)調(diào)節(jié)性T細(xì)胞進(jìn)行了概述,并從腸道菌群對(duì)調(diào)節(jié)性T細(xì)胞的影響及調(diào)節(jié)性T細(xì)胞對(duì)骨形成、骨吸收的影響等方面對(duì)腸道菌群介導(dǎo)調(diào)節(jié)性T細(xì)胞影響骨代謝的研究進(jìn)展進(jìn)行了綜述。

參考文獻(xiàn)/References:

[1] CARUSO R,LO B C,NUNEZ G.Host-microbiota interactions in inflammatory bowel disease[J].Nat Rev Immunol,2020,20(7):411-426.
[2] MILANI C,DURANTI S,BOTTACINI F,et al.The first microbial colonizers of the human gut:composition,activities,and health implications of the infant gut microbiota[J/OL].Microbiol Mol Biol Rev,2017,81(4):e00036-17[2022-05-06].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706746/.
[3] DURACK J,LYNCH S V.The gut microbiome:relationships with disease and opportunities for therapy[J].J Exp Med,2019,216(1):20-40.
[4] CHARLES J F,ERMANN J,ALIPRANTIS A O.The intestinal microbiome and skeletal fitness:connecting bugs and bones[J].Clin Immunol,2015,159(2):163-169.
[5] DING K,HUA F,DING W.Gut microbiome and osteoporosis[J].Aging Dis,2020,11(2):438-447.
[6] SAKAGUCHI S,MIKAMI N,WING J B,et al.Regulatory T cells and human disease[J].Annu Rev Immunol,2020,38:541-566.
[7] SHEVACH E M,THORNTON A M.tTregs,pTregs,and iTregs:similarities and differences[J].Immunol Rev,2014,259(1):88-102.
[8] STEFKA A T,FEEHLEY T,TRIPATHI P,et al.Commensal bacteria protect against food allergen sensitization[J].Proc Natl Acad Sci U S A,2014,111(36):13145-13150.
[9] TANI-ICHI S,SHIMBA A,WAGATSUMA K,et al.Interleukin-7 receptor controls development and maturation of late stages of thymocyte subpopulations[J].Proc Natl Acad Sci U S A,2013,110(2):612-617.
[10] 劉莉,續(xù)珊,焦沃爾,等.調(diào)節(jié)性T細(xì)胞亞群的分化機(jī)制與功能研究進(jìn)展[J].中華耳鼻咽喉頭頸外科雜志,2021,56(5):522-527.
[11] 程愛(ài)榮,程焱,孫保亮.調(diào)節(jié)性T細(xì)胞及其免疫抑制機(jī)制[J].中國(guó)臨床神經(jīng)科學(xué),2014,22(4):438-444.
[12] LYNCH S V,PEDERSEN O.The human intestinal microbiome in health and disease[J].N Engl J Med,2016,375(24):2369-2379.
[13] ROUND J L,MAZMANIAN S K.Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota[J].Proc Natl Acad Sci U S A,2010,107(27):12204-12209.
[14] ARPAIA N,CAMPBELL C,FAN X,et al.Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation[J].Nature,2013,504(7480):451-455.
[15] ATARASHI K,TANOUE T,SHIMA T,et al.Induction of colonic regulatory T cells by indigenous Clostridium species[J].Science,2011,331(6015):337-341.
[16] KNOOP K A,GUSTAFSSON J K,MCDONALD K G,et al.Microbial antigen encounter during a preweaning interval is critical for tolerance to gut bacteria[J/OL].Sci Immunol,2017,2(18):eaao1314[2022-05-06].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759965/.
[17] WANG G,HUANG S,WANG Y,et al.Bridging intestinal immunity and gut microbiota by metabolites[J].Cell Mol Life Sci,2019,76(20):3917-3937.
[18] ABDEL-GADIR A,STEPHEN-VICTOR E,GERBER G K,et al.Microbiota therapy acts via a regulatory T cell MyD88/RORgammat pathway to suppress food allergy[J].Nat Med,2019,25(7):1164-1174.
[19] PANDIYAN P,BHASKARAN N,ZOU M,et al.Microbiome dependent regulation of Tregs and Th17 cells in mucosa[J].Front Immunol,2019,10:426.
[20] RUNYAN C E,LIU Z,SCHNAPER H W.Phosphatidy-linositol 3-kinase and Rab5 GTPase inversely regulate the Smad anchor for receptor activation(SARA)protein independently of transforming growth factor-beta1[J].J Biol Chem,2012,287(43):35815-35824.
[21] ZHAO L,JIANG S,HANTASH B M.Transforming growth factor beta1 induces osteogenic differentiation of murine bone marrow stromal cells[J].Tissue Eng Part A,2010,16(2):725-733.
[22] ZHU L,HUA F,DING W,et al.The correlation between the Th17/Treg cell balance and bone health[J].Immun Ageing,2020,17:30.
[23] TYAGI A M,YU M,DARBY T M,et al.The microbial metabolite butyrate stimulates bone formation via t regulatory cell-mediated regulation of Wnt10b expression[J].Immunity,2018,49(6):1116-1131
[24] DENG Z,ZHANG Q,ZHAO Z,et al.Crosstalk between immune cells and bone cells or chondrocytes[J].Int Immunopharmacol,2021,101(Pt A):108179.
[25] KOBAYASHI Y,UEHARA S,UDAGAWA N,et al.Regulation of bone metabolism by Wnt signals[J].J Biochem,2016,159(4):387-392.
[26] JIANG M,LIU R,LIU L,et al.Identification of osteogenic progenitor cell-targeted peptides that augment bone formation[J].Nat Commun,2020,11(1):4278.
[27] 張鈺涵,梅其炳,牛銀波.短鏈脂肪酸調(diào)控骨代謝的作用及機(jī)制的研究進(jìn)展[J].微生物學(xué)通報(bào),2021:48(11):4306-4314.
[28] YU M,D’AMELIO P,TYAGI A M,et al.Regulatory T cells are expanded by teriparatide treatment in humans and mediate intermittent PTH-induced bone anabolism in mice[J].EMBO Rep,2018,19(1):156-171.
[29] LI J Y,YU M,PAL S,et al.Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota[J].J Clin Invest,2020,130(4):1767-1781.
[30] BOZEC A,ZAISS M M.T regulatory cells in bone remodelling[J].Current Osteoporosis Reports,2017,15(3):121-125
[31] FISCHER L,HERKNER C,KITTE R,et al.Foxp3(+)regulatory T cells in bone and hematopoietic homeostasis[J].Front Endocrinol(Lausanne),2019,10:578.
[32] ROSSI M,RANA I,BUONUOMO P S,et al.Stimulation of treg cells to inhibit osteoclastogenesis in Gorham-Stout disease[J].Front Cell Dev Biol,2021,9:706596.
[33] TAYLOR A,VERHAGEN J,BLASER K,et al.Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta:the role of T regulatory cells[J].Immunology,2006,117(4):433-442.
[34] DAR H Y,AZAM Z,ANUPAM R,et al.Osteoimmunology:the nexus between bone and immune system[J].Front Biosci(Landmark Ed),2018,23:464-492.
[35] YUAN F L,LI X,LU W G,et al.Regulatory T cells as a potent target for controlling bone loss[J].Biochem Biophys Res Commun,2010,402(2):173-176.
[36] SHASHKOVA E V,TRIVEDI J,CLINE-SMITH A B,et al.Osteoclast-primed Foxp3+ CD8 T cells induce T-bet,eomesodermin,and IFN-gamma to regulate bone resorption[J].J Immunol,2016,197(3):726-735.
[37] ZENG Q M,LIU D C,ZHANG X C,et al.Estrogen defi-ciency inducing shifted cytokines profile in bone marrow stromal cells inhibits Treg cells function in OVX mice[J].Cell Mol Biol(Noisy-le-grand),2015,61(2):64-68.
[38] SCHEPPER J D,COLLINS F L,RIOS-ARCE N D,et al.Probiotic lactobacillus reuteri prevents postantibiotic bone loss by reducing intestinal dysbiosis and preventing barrier disruption[J].J Bone Miner Res,2019,34(4):681-698.
[39] TU M Y,HAN K Y,CHANG G R,et al.Kefir peptides prevent estrogen deficiency-induced bone loss and modulate the structure of the gut microbiota in ovariectomized mice[J].Nutrients,2020,12(11):3432.

相似文獻(xiàn)/References:

[1]朱烜燁,梁浩博,賈宇東,等.T淋巴細(xì)胞在股骨頭壞死發(fā)生發(fā)展及臨床診療中的作用[J].中醫(yī)正骨,2024,36(02):68.
[2]孫鵬,郭克淼.腸道菌群介導(dǎo)骨質(zhì)疏松癥發(fā)生發(fā)展機(jī)制的研究進(jìn)展[J].中醫(yī)正骨,2024,36(12):59.

備注/Memo

備注/Memo:
基金項(xiàng)目:上海市臨床重點(diǎn)專科“中醫(yī)骨傷科學(xué)”建設(shè)項(xiàng)目(shslczdzk03901); 上海市慢性筋骨病臨床醫(yī)學(xué)研究中心項(xiàng)目(20MC1920600)通訊作者:石瑛 E-mail:[email protected]
更新日期/Last Update: 1900-01-01